Cruciferous vegetables may help some people protect against lung cancer

October 27, 2005

Eating vegetables from the cabbage family could help individuals with a certain genetic make-up reduce their risk of lung cancer, suggests a research letter in this week's issue of The Lancet.

Whether the consumption of cruciferous vegetables, such as cabbage, broccoli and sprouts, protects against lung cancer is unclear. Some observational studies have shown a protective effect. But a person's genetic status may influence or mask this effect. Cruciferous vegetables are rich in isothiocyanates, which have been shown to have strong chemopreventive properties against lung cancer. Isothiocyanates are eliminated in the body by glutathione-S-transferase enzymes produced by the genes GSTM1 and GSTT1. People who have inactive forms of these genes therefore have higher concentrations of isothiocyanates because of their reduced elimination capacity. Paul Brennan (International Agency for Cancer Research) and colleagues looked at whether the protective effect of cruciferous vegetables was most apparent in these individuals.

The investigators recruited 2141 patients with lung cancer and 2168 age and sex-matched controls from six countries in eastern and central Europe. The researchers gave participants a food questionnaire to fill in and assessed their genetic status from a blood sample. They found that weekly consumption of cruciferous vegetables had a 33% protective effect against lung cancer in people who had an inactive form of the GSTM1 gene. In people who had an inactive GSTT1 gene there was a 37% protective effect, while those with both genes inactivated had a 72% protective effect. The investigators found no protective effect in people with active forms of the genes.

Dr Brennan states: "These data provide strong evidence for a substantial protective effect of cruciferous vegetable consumption on lung cancer."
-end-
Contact: Dr Paul Brennan, Genetic Epidemiology Group, International Agency for Research on Cancer, 150 Cours Albert-Thomas, 69372 Lyon, France. T) +33 (0) 47273 8391 brennan@iarc.fr

Lancet

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.